Item 5. OTHER INFORMATION

Rule 10b5-1 Plan Elections

During the quarter ended September 30, 2023, the following 10b5-1 director and officer trading plan arrangement change occurred:

1.On August 16, 2023, Michael Triplett, President, U.S. Commercial, adopted a 10b5-1 plan. Mr. Triplett's plan provides for the sale of up to 5,379 shares of The Cigna Group common stock through March 15, 2024.

This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934 and the Company's policies regarding insider transactions.